Its increased levels have been associated with enhanced proliferation and reduced apoptosis in cardiomyocytes, contributing to protective effects against ischemia-induced heart failure in animal models and mitigating hypertension-induced cardiac hypertrophy by targeting PDE5A (46). This evidence concerns the gene PDE5A and heart failure.